{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:02:26Z","timestamp":1792828946237,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271092"],"award-info":[{"award-number":["82271092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2024A03J0171"],"award-info":[{"award-number":["2024A03J0171"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-025-02566-4","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:02:11Z","timestamp":1770681731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Extraocular delivery of bioswitchable tri-miR-22-loaded tetrahedral DNA nanostructures for intraocular neovascular and neurodegenerative repair"],"prefix":"10.1038","volume":"11","author":[{"given":"Qiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2566_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature12345","volume":"499","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. LRG1 promotes angiogenesis by modulating endothelial TGF-\u03b2 signalling. Nature 499, 306\u2013311 (2013).","journal-title":"Nature"},{"key":"2566_CR2","doi-asserted-by":"publisher","first-page":"101349","DOI":"10.1016\/j.preteyeres.2025.101349","volume":"106","author":"AI Jobling","year":"2025","unstructured":"Jobling, A. I. et al. Microglial regulation of the retinal vasculature in health and during the pathology associated with diabetes. Prog. Retin Eye Res. 106, 101349 (2025).","journal-title":"Prog. Retin Eye Res."},{"key":"2566_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.ophtha.2025.06.018","volume":"132","author":"N Keean","year":"2025","unstructured":"Keean, N. et al. Baseline OCT Biomarkers Predicting Visual Outcomes in Neovascular Age-Related Macular Degeneration: A Meta-Analysis. Ophthalmology 132, 1241\u20131252 (2025).","journal-title":"Ophthalmology"},{"key":"2566_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16902-5","volume":"11","author":"I Maria","year":"2020","unstructured":"Maria, I. et al. Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion. Nat. Commun. 11, 3173 (2020).","journal-title":"Nat. Commun."},{"key":"2566_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.preteyeres.2016.09.004","volume":"56","author":"M Ronald","year":"2017","unstructured":"Ronald, M. et al. The neural retina in retinopathy of prematurity. Prog. Retin Eye Res 56, 32\u201357 (2017).","journal-title":"Prog. Retin Eye Res"},{"key":"2566_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti, D. A. et al. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat. Rev. Endocrinol. 17, 195\u2013206 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2566_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","volume":"399","author":"JS Heier","year":"2022","unstructured":"Heier, J. S. et al. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet 399, 729\u2013740 (2022).","journal-title":"Lancet"},{"key":"2566_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld, P. J. et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419\u20131431 (2006).","journal-title":"N. Engl. J. Med."},{"key":"2566_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaophthalmol.2017.6565","volume":"136","author":"NM Bressler","year":"2018","unstructured":"Bressler, N. M. et al. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 136, 257\u2013269 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"2566_CR10","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.121.054071","volume":"144","author":"HW Lee","year":"2021","unstructured":"Lee, H. W. et al. Role of Venous Endothelial Cells in Developmental and Pathologic Angiogenesis. Circulation 144, 1308\u20131322 (2021).","journal-title":"Circulation"},{"key":"2566_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","volume":"49","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro, P. A. et al. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog. Retin Eye Res. 49, 67\u201381 (2015).","journal-title":"Prog. Retin Eye Res."},{"key":"2566_CR12","doi-asserted-by":"publisher","first-page":"100921","DOI":"10.1016\/j.preteyeres.2020.100921","volume":"83","author":"PA Campochiaro","year":"2021","unstructured":"Campochiaro, P. A. et al. Sustained suppression of VEGF for treatment of retinal\/choroidal vascular diseases. Prog. Retin Eye Res. 83, 100921 (2021).","journal-title":"Prog. Retin Eye Res."},{"key":"2566_CR13","doi-asserted-by":"publisher","first-page":"8567912","DOI":"10.1155\/2018\/8567912","volume":"2018","author":"PE Lau","year":"2018","unstructured":"Lau, P. E. et al. Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections. J. Ophthalmol. 2018, 8567912 (2018).","journal-title":"J. Ophthalmol."},{"key":"2566_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","volume":"39","author":"S Li","year":"2023","unstructured":"Li, S. et al. The role of microRNAs in neurodegenerative diseases: a review. Cell Biol. Toxicol. 39, 53\u201383 (2023).","journal-title":"Cell Biol. Toxicol."},{"key":"2566_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.preteyeres.2018.02.002","volume":"65","author":"MT Pardue","year":"2018","unstructured":"Pardue, M. T. et al. Neuroprotective strategies for retinal disease. Prog. Retin Eye Res. 65, 50\u201376 (2018).","journal-title":"Prog. Retin Eye Res."},{"key":"2566_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00702-019-02124-7","volume":"127","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. MicroRNA-22 exerts its neuroprotective and angiogenic functions by regulating PI3K\/Akt signaling pathway in cerebral ischemia\u2012reperfusion rats. J. Neural Transm. (Vienna) 127, 35\u201344 (2020).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"2566_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12031-016-0828-2","volume":"60","author":"CP Yang","year":"2016","unstructured":"Yang, C. P. et al. Neuroprotective Role of MicroRNA-22 in a 6-Hydroxydopamine-Induced Cell Model of Parkinson\u2019s Disease via Regulation of Its Target Gene TRPM7. J. Mol. Neurosci. 60, 445\u2013452 (2016).","journal-title":"J. Mol. Neurosci."},{"key":"2566_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.omtn.2021.10.003","volume":"26","author":"G Yuan","year":"2021","unstructured":"Yuan, G. et al. Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis. Mol. Ther. Nucleic Acids 26, 849\u2013864 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2566_CR19","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1126\/science.1120367","volume":"310","author":"RP Goodman","year":"2005","unstructured":"Goodman, R. P. et al. Rapid chiral assembly of rigid DNA building blocks for molecular nanofabrication. Science 310, 1661\u20131665 (2005).","journal-title":"Science"},{"key":"2566_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13407","volume":"56","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. Tetrahedral framework nucleic acids inhibit pathological neovascularization and vaso-obliteration in ischemic retinopathy via PI3K\/AKT\/mTOR signaling pathway. Cell Prolif. 56, e13407 (2023).","journal-title":"Cell Prolif."},{"key":"2566_CR21","doi-asserted-by":"publisher","first-page":"26076","DOI":"10.1021\/acsnano.4c05845","volume":"18","author":"Y Jin","year":"2024","unstructured":"Jin, Y. et al. Framework Nucleic Acids Loaded with Quercetin: Protecting Retinal Neurovascular Unit via the Protein Kinase B\/Heme Oxygenase-1 Pathway. ACS Nano 18, 26076\u201326087 (2024).","journal-title":"ACS Nano"},{"key":"2566_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204287","volume":"34","author":"S Li","year":"2022","unstructured":"Li, S. et al. A Tetrahedral Framework DNA-Based Bioswitchable miRNA Inhibitor Delivery System: Application to Skin Anti-Aging. Adv. Mater. 34, e2204287 (2022).","journal-title":"Adv. Mater."},{"key":"2566_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41596-024-01050-7","volume":"20","author":"S Li","year":"2025","unstructured":"Li, S. et al. A bioswitchable delivery system for microRNA therapeutics based on a tetrahedral DNA nanostructure. Nat. Protoc. 20, 336\u2013362 (2025).","journal-title":"Nat. Protoc."},{"key":"2566_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","volume":"23","author":"NN Osborne","year":"2004","unstructured":"Osborne, N. N. et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin Eye Res. 23, 91\u2013147 (2004).","journal-title":"Prog. Retin Eye Res."},{"key":"2566_CR25","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1167\/iovs.18-23806","volume":"59","author":"H Luo","year":"2018","unstructured":"Luo, H. et al. Resveratrol delays retinal ganglion cell loss and attenuates gliosis-related inflammation from ischemia\u2012reperfusion injury. Invest Ophthalmol. Vis. Sci. 59, 3879\u20133888 (2018).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"2566_CR26","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1021\/jacs.4c16529","volume":"147","author":"R Wang","year":"2025","unstructured":"Wang, R. et al. DNA Framework-Enabled Ocular Barrier Penetration for Microinvasive Antiangiogenic Therapy. J. Am. Chem. Soc. 147, 7545\u20137554 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"2566_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41392-021-00727-9","volume":"6","author":"M Wenjuan","year":"2021","unstructured":"Wenjuan, M. et al. The biological applications of DNA nanomaterials: current challenges and future directions. Signal Transduct. Target Ther. 6, 351 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"2566_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13623","volume":"57","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Tetrahedral framework nucleic acids-based delivery of MicroRNA-22 inhibits pathological neovascularization and vaso-obliteration by regulating the Wnt pathway. Cell Prolif. 57, e13623 (2024).","journal-title":"Cell Prolif."},{"key":"2566_CR29","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1182\/blood-2012-04-396846","volume":"120","author":"S Przemyslaw","year":"2012","unstructured":"Przemyslaw, S. Eyeing central neurons in vascular growth and reparative angiogenesis. Blood 120, 2182\u20132194 (2012).","journal-title":"Blood"},{"key":"2566_CR30","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1182\/blood-2010-10-311589","volume":"117","author":"JS Joyal","year":"2011","unstructured":"Joyal, J. S. et al. Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood 117, 6024\u20136035 (2011).","journal-title":"Blood"},{"key":"2566_CR31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.STR.0000250235.80253.e9","volume":"38","author":"C Michael","year":"2007","unstructured":"Michael, C. et al. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 38, 827\u2013831 (2007).","journal-title":"Stroke"},{"key":"2566_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-025-02292-x","volume":"10","author":"C Zhou","year":"2025","unstructured":"Zhou, C. et al. Serine\/threonine\/tyrosine kinase 1 drives pancreatic carcinogenesis via GSK3\u03b2 sequestration-mediated Wnt\/\u03b2-catenin pathway hyperactivation. Signal Transduct. Target Ther. 10, 205 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"2566_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.preteyeres.2018.11.008","volume":"70","author":"W Zhongxiao","year":"2019","unstructured":"Zhongxiao, W. et al. Wnt Signaling in vascular eye diseases. Prog. Retin Eye Res. 70, 110\u2013133 (2019).","journal-title":"Prog. Retin Eye Res."},{"key":"2566_CR34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.117.028521","volume":"136","author":"MG Tomlinson","year":"2017","unstructured":"Tomlinson, M. G. Eye-Opening Potential for Tetraspanin Tspan12 as a Therapeutic Target for Diseases of the Retinal Vasculature. Circulation 136, 196\u2013199 (2017).","journal-title":"Circulation"},{"key":"2566_CR35","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1089\/jop.2017.0108","volume":"33","author":"JS Eaton","year":"2017","unstructured":"Eaton, J. S. et al. The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology. J. Ocul. Pharm. Ther. 33, 718\u2013734 (2017).","journal-title":"J. Ocul. Pharm. Ther."}],"updated-by":[{"DOI":"10.1038\/s41392-026-02728-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000}}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02566-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:12:25Z","timestamp":1777363945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02566-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2566"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02566-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41392-026-02728-y","URL":"https:\/\/doi.org\/10.1038\/s41392-026-02728-y","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}